 |
|
|
Dolagis Flavoured tablets 50mg (pack of 100) |
|
Dolagis flavoured tablets 50mg for th reduction of inflammation and pain caused by musculoskeletal disorders and degenerative joint disease.
|
|
Presentation
Flavoured, beige coloured clover-shaped tablets scored to divide into four equal parts. Each tablet contains 50 mg of carprofen.
Uses
Dogs: Reduction of inflammation and pain caused by musculoskeletal disorders and degenerative joint disease.
As a follow-up to parenteral analgesia in the management of post-operative pain.
|
|
Dosage and administration
Oral administration: 4 mg carprofen per kg bodyweight per day. An initial dose of 4 mg carprofen per kg bodyweight per day given as a single daily dose. The analgesic effect from each dose persists for at least 12 hours. The daily dose may be reduced, subject to clinical response. Duration of treatment will be dependant upon the response seen. Long term treatment should be under regular veterinary supervision.
To extend analgesic and anti-inflammatory cover post-operatively parenteral pre-operative treatment with an injectable carprofen may be followed with carprofen tablets at 4 mg/kg/day for 5 days.
Do not exceed the stated dose.
|
|
Contra-indications, warnings, etc
Do not use in cats, in pregnant and lactating bitches, in dogs aged less than 4 months in the absence of specific data, in dogs, suffering from cardiac, hepatic or renal disease, when there is a possibility of gastrointestinal ulceration or bleeding or where there is evidence of blood dyscrasia. Do not use in case of hypersensitivity to the active substance, to other NSAIDs and to any of the excipients.
Use in dogs less than 6 weeks of age, or in aged dogs, may involve additional risk. If such a use cannot be avoided, dogs may require a reduced dosage and careful clinical management. Avoid use in any dehydrated, hypovolaemic or hypotensive dog, as there is a potential risk of increased renal toxicity.
Concurrent administration of potential nephrotoxic drugs (e.g. aminogylcoside antibiotics) should be avoided. NSAIDs can cause inhibition of phagocytosis and hence in the treatment of inflammatory conditions associated with bacterial infection, appropriate concurrent antimicrobial therapy should be instigated. As with other NSAIDs, photodermatitis during treatment with carprofen has been observed in laboratory animals and in humans. These skin reactions have never been observed in dogs. Do not administer other NSAIDs concurrently or within 24 hours of each other. Some NSAIDs may be highly bound to plasma proteins and compete with other highly bound drugs, which can lead to toxic effects. Do not use this drug concurrently with other NSAIDs or with glucocorticoids.
Pharmaceutical precautions
Do not store above 30°C. Protect from light.
Keep out of reach of children.
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements
|
|
Legal category
POM-V
Packaging Quantities
Carton containing 10 blisters of 10 tablets.
Further information
Precautions to be taken by the person administering the product to animals: in case of accidental ingestion, seek medical advice immediately and show the package leaflet to the physician.
Marketing authorisation number
Vm 20749/4005.
|
|
|
